Visit Euclid Emerald China

Impact Today’s Myopia Epidemic

Myopia isn’t just a visual disorder, it’s a growing global health epidemic.

By 2050, myopia is expected to become a leading cause of permanent blindness worldwide, with the number of myopes reaching almost 5 billion.1

That’s 5 billion reasons to partner with Euclid.

Scroll Down Button

Inside The Myopia Epidemic

The prevalence of myopia has nearly doubled since the 1970s.2

An entire generation of children is on its way to worse vision and ocular health than their parents. We’re seeing more and more kids with eyeglasses. What’s to blame? While genetics is a factor, science points to increased screen time and less time outdoors as key factors driving this myopia boom.3

Myopia in Children
is a Serious Issue

As an eye care community, we must do more to treat the condition, not just the symptoms.

Despite the industry’s best efforts with glasses and contact lenses, cases of myopia are increasing exponentially. We expect to see almost 5 billion myopes and almost 1 billion high myopes by 2050.1

Myopia significantly increases the risk of:


Glaucoma

14.4X

for myopia >8.00D4


 


Cataract

3.3x

for myopia >6.00D5


 


Retinal Pathology

7.8X

for myopia >8.00D6


 

Shape the Future of Vision with Euclid Emerald

For decades, eye care professionals have treated the symptoms of myopia with stronger and thicker spectacle or contact lens prescriptions.

Now you have the option to proactively manage myopia, to treat it using today’s most innovative form of overnight orthokeratology called Euclid Emerald. This advanced treatment is safe, effective, FDA-approved and proven on over 2 million eyes around the world.

Differentiate Your Practice with Euclid Emerald

Differentiating your practice for growth by providing better eye health to your patients is your number one priority.

Especially with today’s myopia epidemic, Euclid Emerald Ortho-K treatment offers your practice the opportunity to be a part of the solution for myopia management for children.